Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 92 results found. Search for [ SARS CoV-2 antibodies ]

Results 1 to 21 of 92
PTI
June 12, 2021
Prior infections, high seropositivity and partial vaccination are \"insufficient impediments\" to the spread of the Delta variant, found the scientists


BusinessToday.In
June 10, 2021
Both patients were given REGCov2, which has been developed to produce resistance against SARS-CoV-2. Both COVID-19 patients managed to recover from their ailments and were discharged within 12 hours


BusinessToday.In
June 9, 2021
It is very hard to conclusively state whether this virus is of natural or lab origin, unlike the publications which state that it cannot be of lab origin, said the researchers, led by Prof Biswajit Kundu, in a statement


BusinessToday.In
June 9, 2021
The AIIMS chief added that 60-70 per cent of children who were admitted to hospitals due to COVID-19 second wave either had comorbidities or low immunity


BusinessToday.In
June 7, 2021
The study has noted that both Covishield and Covaxin produce a good response after the two doses have been administered. However, seropositivity rate and median anti-spike antibody were significantly higher in Covishield recipients


PB Jayakumar
June 2, 2021
The acquisition of Akorn India helped Biological E create a potential overall manufacturing capacity of over 1 billion doses per annum.


PTI
June 1, 2021
Researchers at the Rockefeller University in the US analysed antibodies present in the blood of Covid patients, tracking the evolution of these molecules


PB Jayakumar
May 27, 2021
Zydus is the only Indian company which claims to have developed a neutralising monoclonal antibodies (mAbs) based cocktail for the treatment of COVID 19


BusinessToday.In
May 27, 2021
Two vaccines developed by China National Biotech Group Co, which is a unit of Sinopharm, showed the efficacy of 72.8 per cent and 78.1 per cent, respectively. The current efficacy rate largely falls in line with Sinopharm's previous claims


Shailendra Shukla
New Delhi, May 22, 2021
Singapore social media outlets issue correction notice on COVID-19 variant following Kejriwal's remarksFacebook and Twitter along with Singapore's largest media house have complied with the government's directive to issue a correction to the users of social media platforms in the city-state after Delhi Chief Minister Arvind Kejriwal tweeted about a new COVID-19 \"Singapore variant\". Singapore's Ministry of Health on Thursday invoked the Protection from Online Falsehoods and Manipulation Act...


BusinessToday.In
May 21, 2021
This kit has been developed for the qualitative detection of IgG antibodies in human serum or plasma, targeting the antigens related to COVID-19 causing SARS-CoV-2 virus


PTI
May 16, 2021
Moderna has been widely used in countries such as Canada, United States and the United Kingdom under emergency use authorisations granted by these countries and the World Health Organisation.


PTI
May 11, 2021
The pan-coronavirus vaccine triggers neutralising antibodies via a nanoparticle composed of the coronavirus part. This part allows the vaccine to bind to the body's cell receptors, and is formulated with a chemical booster called an adjuvant


Reuters
May 5, 2021
Despite the warning, scientists said the federal government did not seek to impose major restrictions to stop the spread of the virus


PTI
April 28, 2021
Developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research, Covaxin was approved for emergency use on January 3


PTI
April 25, 2021
The pan-India serosurvey, conducted by the CSIR, studied the presence of antibodies against SARS-CoV-2, the virus that causes the coronavirus disease (COVID-19), and their neutralisation capability to infer possible risk factors for infection


Rashi Bisaria
New Delhi, April 22, 2021
New COVID-19 mutant in Bengal, escapes antibodies' immunity Scientists have found a new lineage of the SARS-CoV-2 virus named 'B.1.618' in India, which is predominantly circulating in West Bengal. This is the second lineage to be identified from the country. The infection through this variant makes plasma therapy as redundant as an investigational treatment. 600% jump in oxygen demand from hospitals Putting tremendous pressure on the nation's medical infrastructure, the latest surge in ...


BusinessToday.In
April 21, 2021
The new variant, B.1.618 is also called a major immune escape variant, as it can escape immunity even if a person has contracted the virus before and can produce antibodies against it


BusinessToday.In
April 1, 2021
Maharashtra Health Minister Rajesh Tope announced the reduction in RT-PCR tests, halving the price to Rs 500 from Rs 1,000


Reuters
March 30, 2021
Many questions remain unanswered about the virus that sparked the pandemic and the team proposed further research in bats and pangolins in China as well as in southeast Asia


PAGES 1 OF 5  12345